Format

Send to

Choose Destination
Arthritis Res Ther. 2011 Apr 28;13(2):210. doi: 10.1186/ar3305.

Update on peripheral mechanisms of pain: beyond prostaglandins and cytokines.

Author information

1
Institute of Physiology I/Neurophysiology, Jena University Hospital-Friedrich Schiller University, Teichgraben 8, D-07740 Jena, Germany. Hans-Georg.Schaible@mti.uni-jena.de

Abstract

The peripheral nociceptor is an important target of pain therapy because many pathological conditions such as inflammation excite and sensitize peripheral nociceptors. Numerous ion channels and receptors for inflammatory mediators were identified in nociceptors that are involved in neuronal excitation and sensitization, and new targets, beyond prostaglandins and cytokines, emerged for pain therapy. This review addresses mechanisms of nociception and focuses on molecules that are currently favored as new targets in drug development or that are already targeted by new compounds at the stage of clinical trials--namely the transient receptor potential V1 receptor, nerve growth factor, and voltage-gated sodium channels--or both.

PMID:
21542894
PMCID:
PMC3132049
DOI:
10.1186/ar3305
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center